11β-Hydroxysteroid Dehydrogenase Type 2 in Mouse Aorta
- 1 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 42 (4) , 580-587
- https://doi.org/10.1161/01.hyp.0000088855.06598.5b
Abstract
Both isozymes of 11β-hydroxysteroid dehydrogenase, which interconvert active and inactive glucocorticoids, are expressed in the mouse aortic wall. Mice deficient in 11HSD type 2 (which converts active corticosterone into inert 11-dehydrocorticosterone) have hypertension and impaired endothelial nitric oxide activity. It has been suggested that 11HSD2 influences vascular function directly by limiting glucocorticoid-mediated inhibition of endothelium-derived nitric oxide. This study sought to determine (1) the cellular distribution of the 11HSD isozymes within the mouse aortic wall and (2) the influence of 11HSD2 on direct glucocorticoid-mediated changes in aortic function. Mouse aortas were separated into their component layers and RNA extracted for RT-PCR. Both types of corticosteroid (mineralocorticoid and glucocorticoid) receptors and both 11HSD isozymes were expressed in the aortic wall. 11HSD1 expression colocalized with α-smooth muscle actin (a marker for smooth muscle cells), whereas 11HSD2 colocalized with TIE-2 (a marker for endothelial cells). Functional relaxation responses of mouse aortic rings were unaltered after exposure to glucocorticoids for 24 hours. In the presence of l -arginine, glucocorticoids produced an endothelium-independent reduction of contraction; similar results were obtained with aortas from mice with genetic inactivation of 11HSD2. Incubation in medium containing l -arginine reversed the endothelial cell dysfunction associated with 11HSD2 inactivation. Thus, 11HSD2 is appropriately sited to modulate endothelial cell function, but endothelial dysfunction in 11HSD2 knockout mice cannot be explained simply by increased access of corticosterone to endothelial cell corticosteroid receptors. Therefore, additional mechanisms, possibly involving indirect effects of enhanced corticosterone action in the kidney and the resultant hypertension, must be involved.Keywords
This publication has 23 references indexed in Scilit:
- 11β-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolismSteroids, 2002
- Induction of 11β-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuliThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- Glucocorticoids Inhibit the Expression of Calcium-Dependent Potassium Channels in Vascular Smooth MuscleMolecular Genetics and Metabolism, 1999
- Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2Journal of Clinical Investigation, 1999
- The role of corticosteroids in the regulation of vascular toneCardiovascular Research, 1999
- 11β-hydroxysteroid dehydrogenase 1 in adipocytes: Expression is differentiation-dependent and hormonally regulatedThe Journal of Steroid Biochemistry and Molecular Biology, 1998
- Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydrogenase in vitro and in vivoJournal of Endocrinology, 1997
- Protein kinase C and insulin receptor β-subunit serine phosphorylation in cultured foetal rat hepatocytesMolecular and Cellular Endocrinology, 1994
- Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractilitySteroids, 1993
- Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.Proceedings of the National Academy of Sciences, 1990